Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

How has the stratagraft market grown in recent years?

The market for stratagraft has shown a growth of XX (HCAGR) in the last few years. Its growth projects a leap from $XX million in 2024 to $XX million in 2025, with a compound annual growth rate (CAGR) of XX%. This growth in the historical period can be traced back to factors such as a surge in burn injury occurrences, a rise in healthcare spending, increased awareness about innovative wound care techniques, wider clinical applications of bioengineered skin, approval for skin substitutes from regulatory bodies, and a higher demand for efficient treatment methods for burns.

How is the stratagraft market size expected to evolve during the forecast period?

The market scale of stratagraft is predicted to experience an expansion of XX (FCAGR) over the imminent years. It is projected to escalate to a valuation of $XX million by 2029, boasting a compound annual growth rate (CAGR) of XX%. The upswing during the projected period can be traced back to several factors – a surge in diabetes and obesity cases, an expanding elderly demographic, a rise in industrial accidents, an increased inclination towards bioengineered solutions, favorable government initiatives, blossoming healthcare infrastructure in growing markets, along with a mounting occurrence of chronic wounds. The period holds some significant trends such as the slow but steady acceptance of skin substitutes, a drive to minimize morbidity at the donor site, a rise in clinical trials for bioengineered goods, improvements in skin substitute technology, and advancements in protocols for burn care.

Get your stratagraft market report here!

https://www.thebusinessresearchcompany.com/report/stratagraft-global-market-report

Which key drivers are propelling the stratagraft market’s growth?

The growth of the stratagraft market is anticipated to be driven by the increasing number of chronic wounds and burn injuries. These terms refer to conditions where there is damage to the skin or underlying tissue. Chronic wounds are distinguished by their extended healing periods, often due to factors like diabetes or poor circulation. Burns, on the other hand, result from exposure to thermal, chemical, or electrical agents and often necessitate advanced medical treatment for repair and recovery. The uptick in chronic wounds and burns can be attributed to the growing prevalence of diabetes, obesity, an aging population, industrial accidents, and inadequate access to preventive care in many areas. Stratagraft provides an innovative treatment solution for chronic wounds and burn injuries, offering a bioengineered counterpart to traditional skin grafts, and facilitating efficient wound healing while minimizing the need for donor site procedures. For example, as per the World Health Organization (WHO) data in October 2023, a US-based public health agency, roughly 180,000 deaths occur globally due to burns each year, primarily in low- and middle-income countries. In the United States, around 410,000 burn injuries were estimated in 2023, with nearly 40,000 necessitating hospitalizations, highlighting this as an ongoing public health issue. Hence, the increasing cases of chronic wounds and burn injuries are stimulating the growth of the stratagraft market.

What are the market segments in the stratagraft industry?

The stratagraft market covered in this report is segmented –

1) By Indication: Thermal Burns; Full-Thickness Burns

2) By Formulation: Allogeneic Cultured Keratinocytes; Dermal Fibroblasts

3) By End User: Hospitals; Specialized Wound Care Centers; Outpatient Care

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20359&type=smp

Which leading companies are shaping the growth of the stratagraft market?

Major companies operating in the stratagraft market are Mallinckrodt Pharmaceuticals plc

What key trends are currently impacting the stratagraft market’s development?

The central trend observed in the stratagraft market revolves around the concentrated efforts to advance innovative allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen. This innovation is intended to amplify the effectiveness of wound healing and provide a feasible substitute for autografts in treatments for severe burns and skin trauma. These allogeneic cultured keratinocytes and dermal fibroblasts within murine collagen constitute a unique biological structure commonly deployed for skin regrowth and wound mending procedures, especially in cases of harsh burns and skin damage. Illustratively, Mallinckrodt Pharmaceuticals, an American pharmaceutical entity, revealed its recent creation of StrataGraft. This innovative treatment is targeted towards adults suffering from deep partial-thickness thermal burns that still retain unscathed dermal elements and has earned approval from the US-based government institution, the Food and Drug Administration. Moreover, the crucial components of StrataGraft are allogeneic cultured keratinocytes and dermal fibroblasts enveloped in murine collagen, designed to foster healing while simultaneously diminishing the necessity for autografting – the conventional process of employing a patient’s own skin for the sealing of wounds.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20359

Which geographic areas are influencing the growth of the stratagraft market?

North America was the largest region in the stratagraft market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the stratagraft market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Skin Cancer Drugs Global Market Report 2025

https://thebusinessresearchcompany.com/report/skin-cancer-drugs-global-market-report

Parathyroid Hormone Global Market Report 2025

https://thebusinessresearchcompany.com/report/parathyroid-hormones-global-market-report

Global Transdermal Skin Patches Global Market Report 2025

https://thebusinessresearchcompany.com/report/transdermal-skin-patches-market

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: